Your shopping cart is currently empty

SAFit1 is a highly potent and selective inhibitor of FK506 binding protein 51 (FKBP51) with a Ki value of 4 ± 0.3 nM, extensively applied in stress biology, neuropsychiatric disorder research, and metabolic disease studies to dissect FKBP51-specific signaling pathways and evaluate its role as a therapeutic target distinct from closely related FKBP family members.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $74 | 8-10 weeks | 8-10 weeks | |
| 5 mg | $179 | 8-10 weeks | 8-10 weeks | |
| 10 mg | $313 | 8-10 weeks | 8-10 weeks | |
| 25 mg | $662 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $1,090 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $1,880 | 8-10 weeks | 8-10 weeks | |
| 1 mL x 10 mM (in DMSO) | $298 | 8-10 weeks | 8-10 weeks |
| Description | SAFit1 is a highly potent and selective inhibitor of FK506 binding protein 51 (FKBP51) with a Ki value of 4 ± 0.3 nM, extensively applied in stress biology, neuropsychiatric disorder research, and metabolic disease studies to dissect FKBP51-specific signaling pathways and evaluate its role as a therapeutic target distinct from closely related FKBP family members. |
| Targets&IC50 | FKBP52:>50000 nM (KI), FKBP51:4±0.3 nM(ki) |
| In vitro | In neurodevelopmental assays involving N2a, SH-SY5Y neuroblastoma cell lines, and primary hippocampal neurons, SAFit1 acted as a selective FKBP51 inhibitor. It stimulated neurite outgrowth and promoted neuronal differentiation and extension over a concentration range of 1 to 1000 nM [1]. |
| Synonyms | SAFit 1 |
| Molecular Weight | 747.87 |
| Formula | C42H53NO11 |
| Cas No. | 1643125-32-9 |
| Smiles | [C@@H](C(=O)N1[C@H](C(O[C@H](CCC2=CC(OC)=C(OC)C=C2)C3=CC(OCC(O)=O)=CC=C3)=O)CCCC1)(C4=CC(OC)=C(OC)C(OC)=C4)C5CCCCC5 |
| Relative Density. | 1.211 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (106.97 mM), Sonication is recommended. MEthanol: 125 mg/mL (167.14 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (4.41 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO/MEthanol
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.